# Darbepoetin alfa

## NESP inj 20mcg(洗腎用)

##### 

| 藥品代碼   | INESP                                                                                                                                                                                                                                                                                                                                         |
|:-----------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症     | Anemia: Treatment of anemia due to concurrent myelosuppressive chemotherapy in patients with cancer (nonmyeloid malignancies) receiving chemotherapy (palliative intent) for a planned minimum of 2 additional months of chemotherapy; treatment of anemia due to chronic kidney disease (including patients on dialysis and not on dialysis) |
| 用法用量   | Initial dose as 0.45mcg/kg IV or SC every week for treatment of chronic renal failure patient with anemia， keeping Hb between 10-12g/dL. For patient with chemotherapy， 2.25mcg/kg SC as initial dose.                                                                                                                                      |
| 肝功能異常 | 無需調整劑量                                                                                                                                                                                                                                                                                                                                  |
| 腎功能異常 | 無需調整劑量                                                                                                                                                                                                                                                                                                                                  |
| 禁忌       | Hypersensitivity to darbepoetin or any component of the formulation; uncontrolled hypertension; pure red cell aplasia (due to darbepoetin or other erythropoietin protein drugs)                                                                                                                                                              |
| 副作用     | Hypertension (31%)， peripheral edema (17%)， edema (6% to 13%)， Abdominal pain (10% to 13%)， Dyspnea (17%)， cough (12%)                                                                                                                                                                                                                   |
| 孕期建議   | No Data                                                                                                                                                                                                                                                                                                                                       |
| 哺乳期建議 | No (Limited) Human Data - Probably Compatible 無(很少)資料 - 可使用                                                                                                                                                                                                                                                                           |

